Medical Health & Life Science Research News

Research report explores the global bronchodilators industry

Learn details of the Overview, Company Assessment and Forecast Report 2021

- Advertising -

Bronchodilators are a type of medication, which make breathing easy by relaxing the muscles in the lungs and widening the airways (bronchi). They are used to treat the breathing problems, majorly asthma and COPD.

Short-acting bronchodilators are the first-line therapy, which is widely used in bronchodilators. These agents have a short-term (2-4 hours) duration of action and therefore require multiple dosages.

- Advertising -

Whereas, long-acting bronchodilators, which are introduced recently, have an extended period of action. They reduce the process of multiple dosages.

Therefore, they are more effective than the short-term bronchodilators.

Research analysts forecast the Global Bronchodilators Market to grow at a CAGR of 4.78% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global bronchodilators market for 2017-2021. To calculate the market size, the report considers the sales of branded, generic, and off-label drugs.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Report at: www.orbisresearch.com/contacts/request-sample/366291

The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • AstraZeneca
  • Boehringer Ingelheim
  • F. Hoffmann-La Roche
  • GlaxoSmithKline

Other prominent vendors

  • ALK-Abello
  • Amgen
  • Array BioPharma
  • ASMACURE
  • Astellas Pharma
  • Atopix Therapeutics
  • CHIESI Farmaceutici
  • Dynavax Technologies
  • Kissei Pharmaceutical
  • Kyowa Hakko Kirin
  • MediciNova
  • Mitsubishi Tanabe Pharma
  • Mundipharma International
  • Nycomed Pharma
  • Oxagen
  • Pearl Therapeutics
  • Pharmaxis
  • Pulmagen Therapeutics
  • Regeneron Pharmaceuticals
  • Revalesio
  • Sanofi
  • SolAeroMed
  • Stallergenes Greer
  • sterna biologicals
  • Synairgen
  • Theron Pharmaceuticals
  • UCB Pharma
  • Verona Pharma

Market driver

  • Market potential toward mAb
  • For a full, detailed list, view our report

Market challenge

  • Increased preference for CAM
  • For a full, detailed list, view our report

Market trend

  • Innovative technologies for drug delivery
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Companies Mentioned:

AstraZeneca, Boehringer Ingelheim, F. Hoffmann-La Roche, GlaxoSmithKline, ALK-Abello, Amgen, Array BioPharma, ASMACURE, Astellas Pharma, Atopix Therapeutics, CHIESI Farmaceutici, Dynavax Technologies, Kissei Pharmaceutical, Kyowa Hakko Kirin, MediciNova, Mitsubishi Tanabe Pharma, Mundipharma International, Nycomed Pharma, Oxagen, Pearl Therapeutics, Pharmaxis, Pulmagen Therapeutics, Regeneron Pharmaceuticals, Revalesio, Sanofi, SolAeroMed, Stallergenes Greer, sterna biologicals, Synairgen, Theron Pharmaceuticals, UCB Pharma, and Verona Pharma.

 

 

News From

Orbis Research - Rendering Conscientious ResearchOrbis Research
Category: Market Research Publishers and RetailersCompany profile: Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have a vast database of reports from the leading publishers and authors across the gl obe. We specialize in delivering customised reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialisation. This helps our clients to map their need, and we produce the perfect requi ...